Alfact Innovation (France)

Recent papers from Alfact Innovation (France)

1. Tumor suppressive role of the antimicrobial lectin REG3A targeting the O-GlcNAc glycosylation pathwayHepatology · 2024
2. Antimicrobial protein REG3A regulates glucose homeostasis and insulin resistance in obese diabetic miceCommunications Biology · 2023
3. A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver DiseasesPLoS ONE · 2016
4. The Reg3α (HIP/PAP) Lectin Suppresses Extracellular Oxidative Stress in a Murine Model of Acute Liver FailurePLoS ONE · 2015
5. HIP/PAP prevents excitotoxic neuronal death and promotes plasticityAnnals of Clinical and Translational Neurology · 2014
6. Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured liversHepatology · 2010